BRIEF published on 05/02/2025 at 01:55, 1 year 5 months ago BioNxt Solutions Delays 2024 Annual Financial Statement Filing Management Cease Trade Order Healthcare Innovation Financial Statements Delay Annual Filings BioNxt Solutions
PRESS RELEASE published on 05/02/2025 at 01:50, 1 year 5 months ago BioNxt Solutions Announces Delay In Filing 2024 Annual Financial Statements BioNxt Solutions Inc. announces delay in filing annual financial statements for year ended December 31, 2024. Company working on completing filings by June 28, 2025, under management cease trade order Financial Statements Management Cease Trade Order BioNxt Solutions Inc. Delay Regulatory Authorities
BRIEF published on 04/23/2025 at 09:10, 1 year 6 months ago BioNxt Solutions Advances in MS Treatment Study Multiple Sclerosis Cladribine Drug Delivery Innovation BioNxt Solutions Bioequivalence Study
PRESS RELEASE published on 04/23/2025 at 09:05, 1 year 6 months ago BioNxt Solutions Prepares for Human Bioequivalence Study For MS BioNxt Solutions Inc. reports advanced preparation for human bioequivalence study of BNT23001, a novel sublingual thin-film Cladribine formulation for Multiple Sclerosis treatment BioNxt Solutions Inc. Multiple Sclerosis Treatment Sublingual Thin-Film BNT23001 Human Bioequivalence Study
BRIEF published on 03/15/2025 at 00:05, 1 year 7 months ago BioNxt Solutions Closes Final Tranche of Convertible Debenture Offering Private Placement Convertible Debenture Warrants Financing BioNxt Solutions
PRESS RELEASE published on 03/15/2025 at 00:00, 1 year 7 months ago BioNxt Solutions Announces Closing of Final Tranche of Fully Subscribed Convertible Debenture Unit Private Placement BioNxt Solutions Inc. completes final tranche of convertible debenture Offering for $900,000. Funds to be used for product dev, IP, debt repayment, and working capital Private Placement Convertible Debenture Healthcare BioNxt Solutions Inc. Drug Delivery Technologies
BRIEF published on 03/01/2025 at 01:40, 1 year 7 months ago BioNxt Solutions Secures $1.6 Million in Convertible Debenture Private Placement Private Placement Convertible Debenture Investment BioNxt Solutions Proceeds Utilization
PRESS RELEASE published on 03/01/2025 at 01:35, 1 year 7 months ago BioNxt Solutions Announces Closing of First Tranche of Convertible Debenture Unit Private Placement BioNxt Solutions Inc. closes first tranche of convertible debenture units Offering, raising $1.6M. Proceeds for product development, IP filings, debt repayment, and working capital Private Placement BioNxt Solutions Inc. Intellectual Property Product Development Convertible Debenture Units
BRIEF published on 02/24/2025 at 15:05, 1 year 8 months ago BioNxt Solutions Launches Debenture Unit Financing Private Placement Regulatory Approvals Convertible Securities Debenture Units Compensation Warrants
PRESS RELEASE published on 02/24/2025 at 15:00, 1 year 8 months ago BioNxt Solutions Announces Debenture Unit Financing BioNxt Solutions Inc. announces a non-brokered private placement of debenture units and Finders Warrants, expecting gross proceeds of up to $2,500,000, subject to regulatory approvals Private Placement BioNxt Solutions Inc. Regulatory Approvals Debenture Units Finders Warrants
Published on 10/30/2026 at 19:00, 1 hour 25 minutes ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 4 hours 55 minutes ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 10/30/2026 at 12:20, 8 hours 5 minutes ago Silver X Files NI 43-101 Technical Report for the Updated Nueva Recuperada Mineral Resource: 10.4 Mt Measured and Indicated at 202 g/t AgEq (67.3 Moz AgEq) and 21.6 Mt Inferred at 260 g/t AgEq (184.3 Moz AgEq)
Published on 10/30/2026 at 12:00, 8 hours 25 minutes ago Aztec Minerals Strengthens Technical Management Team
Published on 10/29/2026 at 22:01, 22 hours 24 minutes ago Pinetree Capital Announces Unaudited Financial Results for the Period Ended September 30, 2026
Published on 10/30/2026 at 18:38, 1 hour 47 minutes ago EQS-Adhoc: Starcom Holding AD publishes Interim Q3 2026 Financial Report
Published on 10/30/2026 at 18:35, 1 hour 50 minutes ago EQS-Adhoc: hep global GmbH expects to conclude refinancing negotiations only in fiscal year 2027
Published on 10/30/2026 at 17:45, 2 hours 40 minutes ago FORVIA HELLA presents financial results for the first nine months of 2026
Published on 10/30/2026 at 18:00, 2 hours 25 minutes ago 2026 half-year earnings & third quarter revenue
Published on 10/30/2026 at 12:00, 8 hours 25 minutes ago Capital increase through exercise of subscription rights
Published on 10/30/2026 at 08:00, 12 hours 25 minutes ago Neoen secures AUD 1.8 billion in debt financing to support renewable energy portfolio in Australia
Published on 10/29/2026 at 18:02, 1 day 2 hours ago TF1 9M 2026 results - Consolidated financial statements and appendix
